https://www.marketscreener.com/quote/stock/REGENERON-PHARMACEUTICALS-10649/news/Dupixent-dupilumab-Demonstrates-Potential-to-Become-First-Biologic-to-Treat-COPD-by-Showing-Sign-43316087/?utm_source=telegram&utm_medium=social&utm_campaign=share